DIVISLAB.BO

Divi's Laboratories Limited DIVISLAB.BO

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode DIVISLAB.BO TORNTPHARM.BO TORNTPHARM.NS MANKIND.NS MANKIND.BO DRREDDY.BO DRREDDY.NS ZYDUSLIFE.NS ZYDUSLIFE.BO LUPIN.BO
6M 11.45 % 10.63 % 10.61 % -5.19 % -5.00 % 9.76 % 9.68 % 17.22 % 17.29 % -5.06 %
YTD 8.60 % 5.10 % 5.04 % -15.11 % -15.26 % -5.84 % -5.87 % 2.64 % 2.70 % -17.83 %
1Y 13.28 % 7.59 % 7.52 % -4.69 % -4.70 % -3.19 % -3.29 % 1.14 % 1.18 % -8.83 %
3Y 82.54 % 128.88 % 129.11 % 71.95 % 71.82 % 47.31 % 47.20 % 141.95 % 142.02 % 185.72 %
5Y 112.96 % 164.57 % 164.51 % 71.95 % 71.82 % 28.35 % 28.31 % 134.82 % 134.64 % 95.75 %
10Y 507.79 % 353.97 % 354.14 % 71.95 % 71.82 % 54.08 % 53.84 % 125.57 % 125.79 % -6.55 %
From the beginning 60 500.64 % 69 476.55 % 17 306.20 % 71.95 % 71.82 % 3 152.33 % 6 505.33 % -51.44 % 15 450.54 % 3 734.55 %

Dividend

Divi's Laboratories Limited

Torrent Pharmaceuticals Limited

Torrent Pharmaceuticals Limited

Mankind Pharma Limited

Mankind Pharma Limited

Dr. Reddy's Laboratories Limited

Dr. Reddy's Laboratories Limited

Zydus Lifesciences Limited

Zydus Lifesciences Limited

Lupin Limited